M. Merten et P. Thiagarajan, P-selectin expression on platelets determines size and stability of platelet aggregates, CIRCULATION, 102(16), 2000, pp. 1931-1936
Citations number
40
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-P-selectin mediates rolling of platelets and leukocytes on activ
ated endothelial cells. After platelet activation, P-selectin is translocat
ed from intracellular granules to the external membrane, whereas fibrinogen
aggregates platelets by bridging glycoprotein (GP) IIb/IIIa between adjace
nt platelets.
Methods and Results-In this study, we define a novel role for P-selectin in
platelet aggregation. Expression of P-selectin on the platelet surface cor
related strongly with the mean platelet aggregate size. Inhibition of P-sel
ectin binding to its Ligand by either monoclonal anti-P-selectin antibodies
directed against the lectin domain or soluble human P-selectin reversed pl
atelet aggregation even when added up to 5 minutes after activation; howeve
r, fibrinogen binding to platelets was not affected. This deaggregating eff
ect significantly reduced the maximal size and number of platelet aggregate
s. When added I minute after platelet activation, anti-P-selectin antibody
achieved 95% to 100% of the deaggregating effect of EDTA, whereas the anti-
GP IIb/lIIa antibody abciximab had no effect. Monoclonal antibodies against
known P-selectin ligands, such as P-selectin GP ligand-1 (PSGL-1) or GP Ib
, had no effect on platelet aggregation suggesting a different ligand for P
-selectin in platelet aggregate stabilization. In kinetic studies, P-select
in was maximally expressed 10 minutes after platelet activation, whereas ma
ximal activation of GP IIb/IIIa occurred within the first 10 seconds, sugge
sting that P-selectin operates after fibrinogen binding to activated GP IIb
/IIIa.
Conclusions-These results indicate that P-selectin interaction with a ligan
d, different from PSGL-1 or GP Ib, stabilizes initial GP IIb/IIIa-fibrinoge
n interactions, allowing the formation of large stable platelet aggregates.